Tiltan Pharma

About Tiltan Pharma

Yigal Stav,

CEO, Co-founder. Holds M.Sc. degree in Physics, B.Sc. degree in Mathematics and Physics, and an MBA degree. Former CEO of Netafim, irrigation world leader global firm. Chairman and board member of several companies.

 

 

 

 

 

Professor Shmuel (Muli) Ben-Sasson,

Co-founder and Chief Scientific Officer, was Chairman of the Dept. of Experimental Medicine & Cancer Research at The Hebrew University-Hadassah Medical School (Jerusalem).  He also served as Visiting Professor at the Harvard Medical School for 10 years, where he worked in close collaboration with key opinion leaders in the field of anti-angiogenesis, including Prof. Judah Folkman, Dept. Surgical Research, Children’s Hospital (Boston).

 

 

 

 

 

Dr. Osnat Ohne,

Chief Operating Officer, previously served for 10 years as Director in the Global Innovative R&D at Teva Pharmaceutical Industries, where she led pre-clinical and clinical development stages of oncology, and immunology innovative projects.  Dr. Ohne received her PhD in Immunology from Tel Aviv University, Sackler School of Medicine, Microbiology Department.

 

 

icon of a house icon of an envelope

Built by Badboy.co.il

© copyright 2015 Tiltan Pharma